New combo pill could supercharge deworming for millions of kids
NCT ID NCT06282315
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 20 times
Summary
This large study in Ghana and Kenya tests whether a single dose of a new combination pill (albendazole plus ivermectin) works better than the standard deworming pill alone for treating soil-transmitted worm infections. About 20,000 school children aged 5 to 17 will take part. The main goal is to check safety, and a key secondary goal is to see if the combo pill reduces a hard-to-treat worm (whipworm) more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOIL-TRANSMITTED HELMINTHS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ghana Health Service (GHS)
RECRUITINGAccra, Accra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Kenya Medical Research Institution (KEMRI)
RECRUITINGNairobi, Nairobi County, 00200, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.